Market Exclusive

Analyst Activity – Wells Fargo & Co Raises Its Price Target On Foundation Medicine (NASDAQ:FMI) to $80.00

Analyst Ratings For Foundation Medicine (NASDAQ:FMI)

Today, Wells Fargo & Co raised its price target on Foundation Medicine (NASDAQ:FMI) to $80.00 per share.

Some recent analyst ratings include

Recent Insider Trading Activity For Foundation Medicine (NASDAQ:FMI)
Foundation Medicine (NASDAQ:FMI) has insider ownership of 2.70% and institutional ownership of 32.88%.

Recent Trading Activity for Foundation Medicine (NASDAQ:FMI)
Shares of Foundation Medicine closed the previous trading session at 73.69 down -9.56 11.48% with 271762 shares trading hands.

Exit mobile version